These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 28887399)

  • 1. Validation of Postinduction Curie Scores in High-Risk Neuroblastoma: A Children's Oncology Group and SIOPEN Group Report on SIOPEN/HR-NBL1.
    Yanik GA; Parisi MT; Naranjo A; Nadel H; Gelfand MJ; Park JR; Ladenstein RL; Poetschger U; Boubaker A; Valteau-Couanet D; Lambert B; Castellani MR; Bar-Sever Z; Oudoux A; Kaminska A; Kreissman SG; Shulkin BL; Matthay KK
    J Nucl Med; 2018 Mar; 59(3):502-508. PubMed ID: 28887399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the mIBG skeletal SIOPEN scoring method in two independent high-risk neuroblastoma populations: the SIOPEN/HR-NBL1 and COG-A3973 trials.
    Ladenstein R; Lambert B; Pötschger U; Castellani MR; Lewington V; Bar-Sever Z; Oudoux A; Śliwińska A; Taborska K; Biassoni L; Yanik GA; Naranjo A; Parisi MT; Shulkin BL; Nadel H; Gelfand MJ; Matthay KK; Park JR; Kreissman SG; Valteau-Couanet D; Boubaker A
    Eur J Nucl Med Mol Imaging; 2018 Feb; 45(2):292-305. PubMed ID: 28940046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Semiquantitative mIBG scoring as a prognostic indicator in patients with stage 4 neuroblastoma: a report from the Children's oncology group.
    Yanik GA; Parisi MT; Shulkin BL; Naranjo A; Kreissman SG; London WB; Villablanca JG; Maris JM; Park JR; Cohn SL; McGrady P; Matthay KK
    J Nucl Med; 2013 Apr; 54(4):541-8. PubMed ID: 23440556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of diagnostic and end-of-induction Curie scores with tandem high-dose chemotherapy and autologous transplants for metastatic high-risk neuroblastoma: A report from the Children's Oncology Group.
    Streby KA; Parisi MT; Shulkin BL; LaBarre B; Bagatell R; Diller L; Grupp SA; Matthay KK; Voss SD; Yu AL; London WB; Park JR; Yanik GA; Naranjo A
    Pediatr Blood Cancer; 2023 Aug; 70(8):e30418. PubMed ID: 37199022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iodine-123 metaiodobenzylguanidine scintigraphy scoring allows prediction of outcome in patients with stage 4 neuroblastoma: results of the Cologne interscore comparison study.
    Decarolis B; Schneider C; Hero B; Simon T; Volland R; Roels F; Dietlein M; Berthold F; Schmidt M
    J Clin Oncol; 2013 Mar; 31(7):944-51. PubMed ID: 23341514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. I-131 mIBG Scintigraphy Curie Versus SIOPEN Scoring: Prognostic Value in Stage 4 Neuroblastoma.
    Riaz S; Bashir H; Khan SJ; Qazi A
    Mol Imaging Radionucl Ther; 2018 Oct; 27(3):121-125. PubMed ID: 30317848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of ¹²³I-metaiodobenzylguanidine (MIBG) and ¹³¹I-MIBG semi-quantitative scores in predicting survival in patients with stage 4 neuroblastoma: a report from the Children's Oncology Group.
    Naranjo A; Parisi MT; Shulkin BL; London WB; Matthay KK; Kreissman SG; Yanik GA
    Pediatr Blood Cancer; 2011 Jul; 56(7):1041-5. PubMed ID: 21328522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superiority of SPECT/CT over planar 123I-mIBG images in neuroblastoma patients with impact on Curie and SIOPEN score values.
    Černý I; Prášek J; Kašpárková H
    Nuklearmedizin; 2016 Aug; 55(4):151-7. PubMed ID: 27054367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroblastoma mRNAs predict outcome in children with stage 4 neuroblastoma: a European HR-NBL1/SIOPEN study.
    Viprey VF; Gregory WM; Corrias MV; Tchirkov A; Swerts K; Vicha A; Dallorso S; Brock P; Luksch R; Valteau-Couanet D; Papadakis V; Laureys G; Pearson AD; Ladenstein R; Burchill SA
    J Clin Oncol; 2014 Apr; 32(10):1074-83. PubMed ID: 24590653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MIBG avidity correlates with clinical features, tumor biology, and outcomes in neuroblastoma: A report from the Children's Oncology Group.
    DuBois SG; Mody R; Naranjo A; Van Ryn C; Russ D; Oldridge D; Kreissman S; Baker DL; Parisi M; Shulkin BL; Bai H; Diskin SJ; Batra V; Maris JM; Park JR; Matthay KK; Yanik G
    Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28383813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk stratification of high-risk metastatic neuroblastoma: A report from the HR-NBL-1/SIOPEN study.
    Morgenstern DA; Pötschger U; Moreno L; Papadakis V; Owens C; Ash S; Pasqualini C; Luksch R; Garaventa A; Canete A; Elliot M; Wieczorek A; Laureys G; Kogner P; Malis J; Ruud E; Beck-Popovic M; Schleiermacher G; Valteau-Couanet D; Ladenstein R
    Pediatr Blood Cancer; 2018 Nov; 65(11):e27363. PubMed ID: 30015396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative Role of
    Hemrom A; Arora G; Damle NA; Bal C
    Nucl Med Mol Imaging; 2022 Oct; 56(5):236-244. PubMed ID: 36310834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computer-assisted Curie scoring for metaiodobenzylguanidine (MIBG) scans in patients with neuroblastoma.
    Sokol EA; Engelmann R; Kang W; Pinto N; Starkey A; Lai H; Nadel H; Shulkin BL; Pu Y; Appelbaum D; Yanik GA; Cohn SL; Armato SG; Volchenboum S
    Pediatr Blood Cancer; 2018 Dec; 65(12):e27417. PubMed ID: 30198643
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Gassenmaier S; Bares R; Barreuther M; Flaadt T; Lang P; Schaefer JF; Tsiflikas I
    Pediatr Radiol; 2021 Jun; 51(7):1223-1230. PubMed ID: 33544193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Association between Tumour Markers and Meta-iodobenzylguanidine Scans in South African Children with High-risk Neuroblastoma.
    Van Heerden J; Kruger M; Esterhuizen TM; Hendricks M; Du Plessis J; Engelbrecht G; Janse van Vuuren M; van Emmenes B; Uys R; Burger C; Nyakale N; More S; Brink A
    Clin Oncol (R Coll Radiol); 2021 Aug; 33(8):517-526. PubMed ID: 33781675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors associated with metastatic site failure in patients with high-risk neuroblastoma.
    Lucas JT; Wakefield DV; Doubrovin M; Li Y; Santiago T; Federico SM; Merchant TE; Davidoff AM; Krasin MJ; Shulkin BL; Santana VM; Lee Furman W
    Clin Transl Radiat Oncol; 2022 May; 34():42-50. PubMed ID: 35345864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scintigraphic response by 123I-metaiodobenzylguanidine scan correlates with event-free survival in high-risk neuroblastoma.
    Katzenstein HM; Cohn SL; Shore RM; Bardo DM; Haut PR; Olszewski M; Schmoldt J; Liu D; Rademaker AW; Kletzel M
    J Clin Oncol; 2004 Oct; 22(19):3909-15. PubMed ID: 15459212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of Surgical Excision on the Survival of Patients With Stage 4 High-Risk Neuroblastoma: A Report From the HR-NBL1/SIOPEN Study.
    Holmes K; Pötschger U; Pearson ADJ; Sarnacki S; Cecchetto G; Gomez-Chacon J; Squire R; Freud E; Bysiek A; Matthyssens LE; Metzelder M; Monclair T; Stenman J; Rygl M; Rasmussen L; Joseph JM; Irtan S; Avanzini S; Godzinski J; Björnland K; Elliott M; Luksch R; Castel V; Ash S; Balwierz W; Laureys G; Ruud E; Papadakis V; Malis J; Owens C; Schroeder H; Beck-Popovic M; Trahair T; Forjaz de Lacerda A; Ambros PF; Gaze MN; McHugh K; Valteau-Couanet D; Ladenstein RL;
    J Clin Oncol; 2020 Sep; 38(25):2902-2915. PubMed ID: 32639845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency and Prognostic Impact of
    Bellini A; Pötschger U; Bernard V; Lapouble E; Baulande S; Ambros PF; Auger N; Beiske K; Bernkopf M; Betts DR; Bhalshankar J; Bown N; de Preter K; Clément N; Combaret V; Font de Mora J; George SL; Jiménez I; Jeison M; Marques B; Martinsson T; Mazzocco K; Morini M; Mühlethaler-Mottet A; Noguera R; Pierron G; Rossing M; Taschner-Mandl S; Van Roy N; Vicha A; Chesler L; Balwierz W; Castel V; Elliott M; Kogner P; Laureys G; Luksch R; Malis J; Popovic-Beck M; Ash S; Delattre O; Valteau-Couanet D; Tweddle DA; Ladenstein R; Schleiermacher G
    J Clin Oncol; 2021 Oct; 39(30):3377-3390. PubMed ID: 34115544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of early metastatic response by 123I-metaiodobenzylguanidine scintigraphy with overall response and event-free survival in stage IV neuroblastoma.
    Matthay KK; Edeline V; Lumbroso J; Tanguy ML; Asselain B; Zucker JM; Valteau-Couanet D; Hartmann O; Michon J
    J Clin Oncol; 2003 Jul; 21(13):2486-91. PubMed ID: 12829667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.